Silence Therapeutics plc (SLN)

Silence Therapeutics Revenue

In the year 2023, Silence Therapeutics had annual revenue of $32.12M with 52.33% growth. Revenue in the quarter ending December 31, 2023 was $2.66M, a -53.72% decrease year-over-year.

• Revenue (ttm): $32.12M
• Revenue Growth: +52.33%
• P/S Ratio: 31.28
• Revenue / Employee: $294,681
• Employees: 109
• Market Cap: 1.00B USD

Revenue Chart

* The company reports in GBP currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	32.12M	11.03M	52.33%
Dec 31, 2022	21.09M	4.53M	27.38%
Dec 31, 2021	16.55M	9.05M	120.55%
Dec 31, 2020	7.51M	7.18M	2,237.77%
Dec 31, 2019	321.05K	-	-
Dec 31, 2018	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.